Prolactin promotes growth of a spontaneous T cell lymphoma: Role of tumor and host derived cytokines

Cancer Investigation

Volumn 24, Issue 6, 2006, Pages 601-610

  Singh, Mahendra Pal ^a   Sharma, Himanshu ^a   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cytokines; Macrophages; Prolactin; T cell lymphoma

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 2; MESSENGER RNA; PROLACTIN;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; DOSE RESPONSE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA; TUMOR GROWTH;

ANIMALS; ASPARTATE CARBAMOYLTRANSFERASE; CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING); CASPASES; CELL PROLIFERATION; DIHYDROOROTASE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERLEUKIN-1; INTERLEUKIN-2; LYMPHOMA, T-CELL; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MICE; MICE, INBRED BALB C; PROLACTIN; SURVIVAL RATE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33748863808     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900600814573     Document Type: Article

References (41)

1. Tammela, J.; Jungbluth, A.A.; Qian, F.; Santiago, D.; Scanlan, M.J.; et al. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer. Cancer Immun. 2004, 18, 4-10.
2. Reiche, E.M.; Nunes, S.C.; Morimoto, H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004, 5, 617-625.
3. Deftos, L.J.; Barken, I.; Burton, D.W.; Hoffman, R.M.; Geller, J. Direct evidence that PTHrP expression promotes prostate cancer progression in bone. Biochem. Biophys. Res. Commun. 2005, 327, 468-472.
4. Miyazaki, H.; Watabe, T.; Kitamura, T.; Miyazono, K. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene. 2004, 23, 9326-9335.
5. Hammacher, A.; Thompson, E.W.; Williams, E.D.; Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer. Int. J. Biochem. Cell. Biol. 2005, 37, 442-450.
6. Koutsodontis, G.; Vasilaki, E.; Chou, W.C.; Papakosta, P.; Kardassis, D. Physical and functional interactions between members of the tumor suppressor p53 and the Sp families of transcription factors: Importance for the regulation of genes involved in cell cycle arrest and apoptosis. Biochem. J. 2005 Mar 24. [Epub ahead of print]
7. Borg, S.A.; Kerry, K.E.; Royds, J.A.; Battersby, R.D.; Jones, T.H. Correlation of VEGF production with IL1 alpha and IL6 secretion by human pituitary adenoma cells. Eur. J. Endocrinol. 2005, 152, 293-300.
8. Nakamura, S. World Health Organization (WHO) classification of malignant lymphoma-how is the WHO now? Gan To Kagaku Ryoho. 2004, 31, 149-157.
9. Moll, A.; Niwald, A.; Gratek, M.; Stolarska, M. Ocular complications in leukemias and malignant lymphomas in children. Klin Oczna. 2004, 106, 783-787.
10. Zhou, J.; Mauerer, K.; Farina, L.; Gribben, J.G. The role of the tumor microenvironment in hematological malignancies and implication for therapy. Front Biosci. 2005, 10, 1581-1596.
11. Chan, J.K.C. Practical lymphoma Diagnosis: A simplified approach. 2001. Presented at 111th semi-annual meeting. California.
12. Ben-Effrain, S. One hundred years of cancer immunotherapy: a critical appraisal. Tumor Biol. 1999, 20, 1-24.
13. Klein, G. Comparative studies of mouse tumors with respect to their capacity for growth as 'Ascitic tumors' and their average nucleic acid content. Exp. Cell Res. 1951, 2, 518-524.
14. Goldie, H.; Felix, M.D. Growth characteristics of free tumor cells transformed serially in the peritoneal fluid of mouse. Cancer Res. 1951, 11, 73-80.
15. Singh, M.P.; Rai, A.K.; Singh, S.M. Gender dimorphism in the progressive in vivo growth of a T cell lymphoma: involvement of cytokines and gonadal hormones. J. Reprod Immunol. 2005, 65, 17-32.
16. Kumar, A.; Singh, S.M. Effect of tumor growth on the blastogenic response of splenocytes: A role of macrophage derived nitric oxide. Immunological Invest. 1996, 25 (5&6), 413-423.
17. Bharti, A.; Singh, S.M. Inhibition of macrophage nitric oxide production by gangliosides derived from a spontaneous T-cell lymphoma: the involved mechanisms. Nitric oxide. 2003, 8, 75-82.
18. Yu-Lee, L.Y. Prolactin modulation of immune and inflammatory responses. Recent Prog. Horm. Res. 2002, 57, 435-455.
19. Clevenger, C.V.; Kline, J.B. Prolactin receptor signal transduction. Lupus. 2001, 10, 706-718.
20. Longhi, S.A.; Miranda, M.E.; Gobet, M.G.; Retegui, L.A. A monoclonal antibody recognizing an epitope shared by receptors for growth hormone, prolactin, interleukin 2 and interleukin 6. Mol. Cell Biochem. 1999, 195, 235-243.
21. Singh, U.P.; Ghose, R.; Ghose, A.K.; Sodhi, A.; Singh, S.M.; et al. The effect of histidine on the structure and antitumor activity of metal-5-halouracil complexes. J. Inorg. Biochem. 1989, 37, 325-339.
22. Parajuli, P.; Singh, S.M.; Kumar, A.; Sodhi, A. Alterations in the tumoricidal function of murine tumor-associated macrophages during progressive growth of a tumor in vivo. Cancer J. 1997, 10, 222-228.
23. Bharti, A.; Singh, S.M. Induction of apoptosis in bone marrow cells by gangliosides produced by a T cell lymphoma. Immunol Letters. 2000, 72, 39-48.
24. Kumar A.; Singh S.M.; Parajuli, P. Modulatory effect of Dalton's Lymphoma cells on the production of reactive nitrogen intermediates, interleukin-1 and tumor necrosis factor by murine peritoneal macrophages. Neoplasma. 1994, 41, 363.
25. Sellins, K.S.; Cohen, J.J. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 1987, 139, 199-206.
26. Bradford, M.M. A rapid and sensitive method for the Quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem. 1976, 72, 248-254.
27. Davis, B.J. Disc electrophoresis-II. Method and application to human serum proteins. Ann. N. Y. Acad. Sci. 1964, 121, 404-414.
28. Ogushi, F.; Sone, S.; Singh, S.M.; Tani, K.; Ozaki, T.; et al. Elevated level of soluble Interleukin-2 receptor in bronchoalveolar lavage fluid from asrcoidosis patients. Jpn. J. Med. 1991, 30, 113-117.
29. Curie, A.D.; Stewart, A.G.; Willaim, A.S. Alveolar macrophages bind and phagocytose allergen containing pollen starch granules via C-type lectin and integrin receptors: implication for airway inflammatory disease. J. Immunol. 2000, 164, 3878-3888.
30. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Meth. 1983, 65, 55-63.
31. Neeck, G.; Federlin, K.; Graef, V.; Schatz, H.; Schmidt, K.L. Endocrine rhythms in patients with rheumatoid arthritis: possible neurohormonal influence n immunological reactions. Immun. Infekt. 1987, 15, 135-140.
32. Gouilleux, F.; Moritz, D.; Humar, M.; Moriggl, R.; Berchtold, S.; et al. Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor. Endocrinology. 1995, 136, 5700-5708.
33. Cornish, J.; Grey, A.; Callon, K.E.; Naot, D.; Hill, B.L.; et al. Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1. Biochem. Biophys. Res. Commun. 2004, 318, 240-246.
34. Carreno, P.C.; Sacedon, R.; Jimenez, E.; Vicente, A.; Zapata AG. Prolactin affects both survival and differentiation of T-cell progenitors. J. Neuroimmunol. 2005, 160, 135-145.
35. Murphy, W.J.; Durum, S.K.; Longo, D.L. Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 1993, 178, 231-236.
36. Manna, P.R.; El-Hefnawy, T.; Kero, J.; Huhtaniemi, I.T. Biphasic action of Prolactin in the regulation of murine Leydig tumor Cell functions. Endocrinology. 2001, 142, 308-318.
37. McDermott, R.S.; Deneux, L.; Mosseri, V.; Vedrenne, J.; Clough, K.; et al. Circulating macrophage colony stimulating factor as a marker of tumour progression. Eur. Cytokine Netw. 2002, 13, 121-127.
38. Michiel, D.F.; Oppenheim, M. Cytokines as positive and negative regulators of tumor promotion and progression. Semin. Cancer Biol. 1992, 3, 3-15.
39. Bailey, J.P.; Nieport, K.M.; Herbst, M.P.; Srivastava, S.; Serra, R.A.; et al. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway. Mol. Endocrinol. 2004, 18, 1171-1184.
40. Le Meur, Jose, M.D.; Mu, W.; Atkins, R.C.; Chadhan, S.J. Macrophage clony stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation, 2002, 73, 1318-1324.
41. McDermott, R.S.; Deneux, L.; Mosseri, V.; Vedrenne, J.; Clough, K.; et al. Circulating macrophage colony stimulating factor as a marker of tumour progression. Eur. Cytokine Netw. 2002, 13, 121-127.